Azenta, Inc.

NASDAQ:AZTA

Medical - Instruments & Supplies

Healthcare
$48.69 -0.11%

-$0.03 today

Market cap
$2.13B
Beta
1.40
P/E (TTM)
-5.9
EPS (TTM)
-$3.87
52W Low $15.93High $41.73

Volume 0.69M

Average 1.16M

AZTA Inventory

Raw materials, work in progress, and finished goods held for sale.

Azenta, Inc.NASDAQ: AZTA

Inventory · Q4 FY2026 · quarter ended Sep 2026

Inventory rises 2.9% from a year ago

Inventory stood at $77.12M at the end of Q4 FY2026, up 2.9% from a year earlier and down 2.5% from the prior quarter. Over 3 fiscal years it compounded at -15.6% a year.

Context

  • Inventory amounted to 4.5% of total assets at the end of Q4 FY2026, up 0.9 pp from a year earlier.
  • Inventory increased in 1 of the last 3 fiscal years.

What to watch

Whether inventory keeps rising in the next quarterly balance sheet after a +2.9% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2026
$77.12M-2.5% QoQ
Last fiscal yearSep 2026
$77.12M+2.9% YoY
Year agoSep 2025
$74.96M+2.9% since
Inventory past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+2.9%——
1 year+2.9%——
3-year CAGR-15.6%——
5-year CAGR——
10-year CAGR——

Inventory history

USD · from the balance sheet

Latest · FY2026
77.12M USD
Year-over-year change
+2.9%
4-year CAGR
-2.6%

Inventory vs competitors

How AZTA compares with its peers on the latest reported figures

  • AZTA's Sep 2026 inventory of $77.12M is the 8th highest of the 10 companies compared; the peer median is $780.6M.
  • Its year-over-year change of +2.9% is the 5th highest of 10, against a peer median of -1.8%.
  • Inventory amounts to 4.5% of total assets for AZTA, versus a peer median of 7.3%.
AZTA Competitors Peer median
Inventory for AZTA and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
TMOThermo Fisher Scientific Inc.Sep 2026$5.64B -1.8%-1.3%4.9%
DHRDanaher CorporationSep 2026$3.13B +17.2%-3.4%3.4%
BRKRBruker CorporationJun 2026$1.12B -8.1%+11.0%18.5%
SOLVSolventum CorporationJun 2026$1.04B +8.1%+6.9%7.3%
BIOBio-Rad Laboratories, Inc.Jun 2026$780.6M -2.3%+1.0%7.6%
TECHBio-Techne CorporationSep 2026$197.67M -2.7%+4.5%7.5%
NEOGNeogen CorporationAug 2026$146.1M -24.5%+2.5%4.4%
AZTAAzenta, Inc.Sep 2026$77.12M +2.9%-15.6%4.5%
BLFSBioLife Solutions, Inc.Mar 2026$32.83M +19.1%-4.8%8.2%
MLABMesa Laboratories, Inc.Mar 2026$26.37M +4.0%-8.7%6.2%
Peer median (excluding AZTA) $780.6M-1.8%+1.0%7.3%

Competitors are the stored peer set for AZTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
FY2026
Sep 2026
Cash & Equivalents658.27M678.91M310.93M279.78M193.8M
Short-term Investments911.76M338.87M151.16M61.14M138.89M
Net Receivables163.76M156.54M172.71M189.21M154.14M
Inventory85.54M128.2M115.26M74.96M77.12M
Other Current Assets507.39M116.44M82.75M103.25M59.6M
Total Current Assets2.46B1.42B832.81M708.34M623.54M
Property, Plant & Equipment (Net)154.47M205.74M266.65M208M234.26M
Goodwill513.62M784.34M691.41M702.4M546.26M
Intangible Assets178.4M294.3M248.03M101.81M80M
Long-term Investments352.02M111.34M49.45M247.19M169.2M
Tax Assets1.17M571K837K726K499K
Other Non-current Assets57.09M70.47M10.86M91.12M54.63M
Total Non-current Assets1.26B1.47B1.27B1.35B1.08B
Total Assets3.72B2.89B2.1B2.06B1.71B
Account Payables38.65M35.8M44.43M37.72M55.22M
Short-term Debt0007.78M0
Tax Payables28.42M7.38M13.28M9.73M10.72M
Deferred Revenue39.75M34.61M31.98M32.57M40.08M
Other Current Liabilities81.83M99.23M104.5M114.39M59.21M
Total Current Liabilities230.55M210.93M204.84M237.67M233.09M
Long-term Debt00051.24M0
Deferred Tax Liabilities66.24M67.68M54.18M18.25M15.34M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities6.72M12.18M11.93M(28.61M)10.86M
Total Non-current Liabilities122.19M140.29M126.24M93.02M78.08M
Total Liabilities352.74M351.22M331.07M330.7M311.16M
Common Stock885K713K590K594K553K
Retained Earnings1.66B1.64B1.48B1.42B1.25B
Accumulated OCI(83.92M)(62.43M)(13.46M)(22.21M)(77.4M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity3.36B2.53B1.77B1.73B1.4B
Total Debt49.23M60.44M70.68M111.17M51.87M
Net Debt(609.05M)(618.47M)(240.25M)(168.61M)(141.92M)

Azenta, Inc.

NASDAQ:AZTA

Intrinsic Alpha fair value

Locked

Current Price

$48.69

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.